cpt code for tirzepatide 90471 Explained Tirzepatide Dosing - A Patient

Real people

GLP-1 users are flocking to personal trainers and supplement aisles, in the hopes of countering muscle loss that has been associated with the drug

Its a metabolic regulator that affects insulin signalling, digestion, and muscle retention

Your body needs time to adjust to each: GLP-1 receptor: Slows gastric emptying, reduces appetite GIP receptor: Enhances insulin signaling, affects fat metabolism Glucagon receptor: Increases energy expenditure, promotes fat oxidation Jumping to high doses overwhelms these systems, causing: Severe nausea and vomiting Treatment discontinuation Longer overall time to reach therapeutic doses The data: In the Phase 2 NEJM study, participants who started at 4 mg instead of 2 mg had significantly higher rates of gastrointestinal side effects